HOME   |    PDF   |   


Title

Molecular docking studies of α-mangostin with oral cancer targets ARRB1, FLNA, CALM3 and HTT

 

Authors

1Janardhanan Sunitha*, 2Jaideep Mahendr, 3Little Mahendra & 2Nalini Devaraj

 

Affiliation

1MAHER, India, 2Meenakshi Ammal Dental College and Hospital, India, 3Maktoum Bin Hamdan Dental University College, India,

 

Email

Sunitha janardhanan E-mail: sunijana@rediffmail.com; *Corresponding author

 

Article Type

Research Article

 

Date

Submitted on July 25, 2020; Revision July 26, 2020; Accepted July 29, 2020; Published August 31, 2020

 

Abstract

Background and Aim: The genes ARRB1, FLNA, CALM3, and HTT are commonly expressed in oral cancer and have been hypothesized to be involved in the carcinogenic pathway. The present study investigates the inhibitive properties of alpha mangostin on the above gene using Autodock molecular docking tool. Materials and Methods: The structures of the proteins were downloaded from the protein databank with PDB IDs 3HOP, 2F3Z, IZSH and 3IO6F for the genes FLNA, CALM3, ARRB1 and HTT, respectively. Autodock was used for molecular docking of the target proteins with the ligand molecule. Results shows HTT having good inhibition features with the Alpha Mangostin followed by the CALM3, FLNA and finally ARRB1 in the decreasing order. CALM3 gene had the lowest binding energy, which easily bound with the target ligand with greater affinity towards the binding followed by ARRB1, HTT, FLNA in the increasing order of binding energy and decreasing order of binding affinity. CALM3 and HTT were promising targets for anticancer treatment using alpha mangostin. Future exploration of the interaction of alpha mangostin and these genes could delineate the role of alpha mangostin as an anticancer agent.

 

Keywords

Oral Cancer, Alpha mangostin, Molecular Docking

 

Citation

Sunitha et al. Bioinformation 16(8): 625-630 (2020)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.